Antirheumatic Agents [clinicaltrials_resource:f8dfc908530a10faf6eee2f40b9e5d0e]
Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) [clinicaltrials:NCT00117091]clinicaltrials:NCT00124982clinicaltrials:NCT00443651A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis [clinicaltrials:NCT00448383]Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy [clinicaltrials:NCT00646178]clinicaltrials:NCT00720798clinicaltrials:NCT00747214An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) [clinicaltrials:NCT00766402]clinicaltrials:NCT00828997clinicaltrials:NCT00848354clinicaltrials:NCT00891020INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs [clinicaltrials:NCT00902486]clinicaltrials:NCT00908089Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan [clinicaltrials:NCT00944320]clinicaltrials:NCT00951275clinicaltrials:NCT00977106clinicaltrials:NCT00996203clinicaltrials:NCT01039688Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain [clinicaltrials:NCT01040195]clinicaltrials:NCT01083693clinicaltrials:NCT01084668Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) [clinicaltrials:NCT01088360]National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) [clinicaltrials:NCT01095393]Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) [clinicaltrials:NCT01136694]clinicaltrials:NCT01144598clinicaltrials:NCT01162421clinicaltrials:NCT01194414clinicaltrials:NCT01197534A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis [clinicaltrials:NCT01225393]clinicaltrials:NCT01231321clinicaltrials:NCT01235507Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement [clinicaltrials:NCT01292616]clinicaltrials:NCT01313208A Phase 2b/3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Methotrexate in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate or to Any Disease-Modifying Antirheumatic Drug [clinicaltrials:NCT01410695]Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s) [clinicaltrials:NCT01489384]Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy [clinicaltrials:NCT01490450]clinicaltrials:NCT01511003clinicaltrials:NCT01519791clinicaltrials:NCT01521923clinicaltrials:NCT01559038
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Antirheumatic Agents [clinicaltrials_resource:f8dfc908530a10faf6eee2f40b9e5d0e]
Bio2RDF identifier
f8dfc908530a10faf6eee2f40b9e5d0e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f8dfc908530a10faf6eee2f40b9e5d0e
identifier
clinicaltrials_resource:f8dfc908530a10faf6eee2f40b9e5d0e
title
Antirheumatic Agents
@en
type
label
Antirheumatic Agents [clinicaltrials_resource:f8dfc908530a10faf6eee2f40b9e5d0e]
@en